Retatrutide (5mg, 10mg)
Price range: $99.95 through $179.99
Triple-agonist peptide for metabolic and endocrine receptor research
Overview [research use only]
Retatrutide (also known as LY-3437943) is a synthetic peptide designed as a triple agonist targeting GLP-1, GIP, and glucagon receptors. This multi-receptor activity enables the simultaneous modulation of appetite, energy expenditure, lipolysis, and glycemic control, making it a promising compound in research on obesity and metabolic regulation. In preclinical and clinical studies, high-dose treatment has demonstrated significant body weight reduction over extended time frames.
Specifications
- Synonyms:
Retatrutide, LY-3437943, NOP2Y096GV - Molecular formula:
- C₂₂₃H₃₄₃F₃N₄₆O₇₀
- Molecular weight:
~ 4 731.3 g/mol - CAS number:
2381089-83-2 - Appearance:
White lyophilized (freeze-dried) powder
Packaging and Storage
Supplied as a lyophilized powder in vials (5 mg or 10 mg). Store at –20 °C for long-term preservation. Upon reconstitution, store aliquots at 2–8 °C or –20 °C and use within recommended time frames, minimizing repeated freeze–thaw cycles.
Safety and Legal
For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.
| Weight | .5 lbs |
|---|---|
| Dimensions | .63 × .63 × 1.4 in |
| Sizes |
10mg ,5mg |
Related products
GW-501516: Cardarine (10 mg/mL, 50 mL)
In stock
RAD-140 (10 mg/mL, 50 mL)
Available on backorder
Tirz (5 mg, 10 mg)
In stock
